-
Biotech Most Active – Exelixis, Inc. (NASDAQ:EXEL), Gilead Sciences, Inc. (NASDAQ:GILD), Galena Biopharma Inc (NASDAQ:GALE), Cell Therapeutics Inc (NASDAQ:CTIC)
Exelixis, Inc. (NASDAQ:EXEL) said Thursday that it has priced its overnight underwritten public offering of 10 million shares of newly issued common stock at a price to the public of $8.00 per share. Shares of Exelixis, Inc. (EXEL) closed at $8.01 in last trading session. Yesterday share price of the company was traded in the…
-
Stock to Watch: Galena Biopharma Inc (NASDAQ:GALE), NuPathe Inc (NASDAQ:PATH), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Pluristem Therapeutics Inc. (NASDAQ:PSTI)
Analysts at Maxim Group lifted their price target on shares of Galena Biopharma Inc (NASDAQ:GALE) from $9.00 to $11.00 in a research report issued to clients and investors on Tuesday, StockRatingsNetwork.com reports. Maxim Group’s target price suggests a potential upside of 57.14% from the company’s current price. Galena Biopharma Inc (NASDAQ:GALE) price to sales ratio…
-
Biotech Watchlist – VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Galena Biopharma Inc (NASDAQ:GALE)
VIVUS, Inc. (NASDAQ:VVUS) announced that the company is collaborating with major insurance carrier Aetna (AET) to begin a pilot program incorporating the prescription weight loss drug Qsymia with lifestyle changes to manage weight. Shares of VIVUS, Inc. (NASDAQ:VVUS) closed at $9.18 in last trading session. Yesterday share price of the company was traded in the range…
-
Biotech Most Active – Rexahn Pharmaceuticals (NYSEMKT:RNN), Mast Therapeutics Inc (NYSEMKT:MSTX), Galena Biopharma (NASDAQ:GALE), Dendreon Corporation (NASDAQ:DNDN)
Shares of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) rose Monday after last week an analyst said the company has found a good path forward. Shares of Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN) closed at $1.60 in last trading session. Yesterday share price of the company was traded in the range of $1.41to $1.85. Company now has a market…
-
Biotech Most Active – Gilead Sciences (NASDAQ:GILD), Cell Therapeutics Inc (NASDAQ:CTIC), Galena Biopharma Inc (NASDAQ:GALE), Ariad Pharmaceuticals (NASDAQ:ARIA)
Gilead Sciences, Inc. (NASDAQ:GILD) had a very successful 2013 driven by its strong product portfolio. The biopharmaceutical company ended the year on a high with its blockbuster hopeful, Sovaldi, gaining U.S. approval for treating patients suffering from chronic hepatitis C virus (HCV). Shares of Gilead Sciences, Inc. (NASDAQ:GILD) closed at $75.21 in last trading session.…
-
Biotech Most Active – Galena Biopharma Inc (NASDAQ:GALE), Gilead Sciences, (NASDAQ:GILD), CytRx Corporation (NASDAQ:CYTR), MannKind Corporation (NASDAQ:MNKD)
Galena Biopharma Inc (NASDAQ:GALE) announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, presented a corporate update at the Oppenheimer 24th Annual Healthcare Conference Shares of Galena Biopharma Inc (NASDAQ:GALE) closed at $4.29 during last trading session. The share price of the company yesterday traded in the range of $4.09 – $4.35. The…
-
Major Pharma/Biotech Companies To Benefit From Personalized Medicine – (ARNA, CTIC, SVNT, GALE)
A report on key facts of the personalized medicine industry and its impact on the health system revealed that individualized or personalized medicine plans to boost the value of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics are expected to be more specific and effective thus giving pharma/biotech companies a…